XML 80 R66.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Segment information                      
Adjusted EBITDA                 $ 537,992 $ 465,807 $ 399,165
Depreciation and amortization                 (160,011) (145,311) (104,981)
Stock compensation expense                 (19,284) (17,413) (14,679)
Income from operations $ 76,352 $ 72,098 $ 115,663 $ 91,765 $ 55,745 $ 56,162 $ 101,054 $ 86,886 355,878 299,847 274,790
Loss on early retirement of debt                 (19,719) (11,626) 0
Equity in earnings of unconsolidated subsidiaries                 21,054 19,943 16,811
Non-operating gain (loss)                 (49) 42,651 29,647
Interest income (expense)                 (154,703) (170,081) (112,816)
Income before income taxes                 202,461 180,734 208,432
Operating Segments | Long Term Acute Care                      
Segment information                      
Adjusted EBITDA                 252,679 224,609 258,223
Depreciation and amortization                 (45,743) (43,862) (45,234)
Stock compensation expense                 0 0 0
Acquisition costs                 0 0 0
Income from operations                 206,936 180,747 212,989
Operating Segments | Inpatient Rehabilitation                      
Segment information                      
Adjusted EBITDA                 90,041 56,902 69,400
Depreciation and amortization                 (20,176) (12,723) (8,758)
Stock compensation expense                 0 0 0
Acquisition costs                 0 0 0
Income from operations                 69,865 44,179 60,642
Operating Segments | Outpatient Rehabilitation                      
Segment information                      
Adjusted EBITDA                 132,533 129,830 98,220
Depreciation and amortization                 (24,607) (22,661) (13,053)
Stock compensation expense                 0 0 0
Acquisition costs                 0 0 0
Income from operations                 107,926 107,169 85,167
Operating Segments | Concentra                      
Segment information                      
Adjusted EBITDA                 157,561 143,009 48,301
Depreciation and amortization                 (61,945) (60,717) (33,644)
Stock compensation expense                 (993) (770) (1,016)
Acquisition costs                 (2,819) 0 (4,715)
Income from operations                 91,804 81,522 8,926
Other                      
Segment information                      
Adjusted EBITDA                 (94,822) (88,543) (74,979)
Depreciation and amortization                 (7,540) (5,348) (4,292)
Stock compensation expense                 (18,291) (16,643) (13,663)
Acquisition costs                 0 (3,236) 0
Income from operations                 $ (120,653) $ (113,770) $ (92,934)